Association of endogenous tissue plasminogen activator (t-PA) with clinical characteristics of the insulin resistance syndrome.
Amowitz
L L
LL
Women's Health, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Manson
J E
JE
Ridker
P M
PM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure; D001824:Body Constitution; D015992:Body Mass Index; D008076:Cholesterol, HDL / Q000097:blood; D016001:Confidence Intervals; D003430:Cross-Sectional Studies; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010959:Tissue Plasminogen Activator / Q000097:blood*; D014280:Triglycerides / Q000097:blood
D008076:Cholesterol, HDL; D014280:Triglycerides; D010959:Tissue Plasminogen Activator